R0012055 |
diABZI STING agonist-1 |
diABZI STING agonist-1 is a selective stimulator of interferon genes (STING) rec
|
R0012056 |
STING agonist-3 |
STING agonist-3, extracted from patent WO2017175147A1 (example 10), is a selecti
|
R0012057 |
CC-885 |
CC-885 is a cereblon (CRBN) modulator with potent anti-tumour activity. CC-885 i
|
R0012058 |
NVP-DKY709 |
NVP-DKY709 is a potent IKZF2 inhibitor for the research of cancers.
|
R0012059 |
Migoprotafib(GDC-1971) |
Migoprotafib (GDC-1971) (compound 199) is a SHP2 inhibitor.
|
R0012060 |
G150 |
G150 is a highly selective human cyclic GMP-AMP synthase (h-cGAS) inhibitor with
|
R0012061 |
LSN3318839 |
LSN3318839 is an orally efficacious positive allosteric modulator of the glucago
|
R0012062 |
(S,R)-LSN3318839 |
(S,R)-LSN3318839 is the stereoisomer of LSN3318839 (HY-142162). LSN3318839 is an
|
R0012063 |
GLP-1受体激动剂1 |
Orforglipron (LY3502970) (Compound 67) is an orally active agonist for Glucagon-
|
R0012064 |
AZD0780(PCSK9-IN-12) |
PCSK9-IN-12 is a heteroaryl compound. PCSK9-IN-12 has bind affinity for PCSK9 wi
|
R0012065 |
Tri-GalNAc(OAc)3 TFA |
Tri-GalNAc(OAc)3 TFA is a tri-GalNAc ligand that can be used for the synthesis o
|
R0012066 |
1426159-34-3 |
|
R0012067 |
(3R,5S)-5-((双(4-甲氧基苯基)(苯基)甲氧基)甲基)吡咯烷-3-醇 |
|
R0016001 |
DPO-1 |
DPO-1 is a potent inhibitor of the voltage-gated potassium channel subtype Kv1.5
|
R0016002 |
EN523 |
EN523 is a OTUB1 recruiter. EN523 targets a non-catalytic allosteric cysteine C2
|
R0016003 |
VX-150 |
VX-150 is an orally active, highly selective NaV1.8 inhibitor. VX-150 has the po
|
R0016004 |
Elexacaftor;VX-445 |
Elexacaftor (VX-445, Compound 1) is a modulator of cystic fibrosis transmembrane
|
R0016007 |
TPN171 |
TPN171 is a potent, selective and oral bioavailable inhibitor of phosphodiestera
|
R0016008 |
Puromycin dihydrochloride (CL13900 dihydrochloride) |
Puromycin dihydrochloride (CL13900 dihydrochloride), an aminonucleoside antibiot
|
R0016009 |
Zoledronic acid impurity A |
Zoledronic acid impurity A
|
R0016010 |
Bendamustine Desmethyl Impurity |
N-desmethyl Bendamustine
|
R0016011 |
EIDD-2749 |
EIDD-2749 (4'-Fluorouridine) is an orally active RdRp inhibitor. EIDD-2749 effec
|
R0016012 |
Fludarabine-Cl |
Fludarabine-Cl has inhibition effect on RNA adenosine deaminase 1(ADAR1), and ca
|
R0016013 |
GW274150 dihydrochloride |
GW274150 (dihydrochloride) is a potent, selective, orally active and NADPH-depen
|
R0016014 |
GW274150 |
GW274150 is a potent, selective, orally active and NADPH-dependent inhibitor of
|